Eupraxia Pharmaceuticals Inc. (EPRX): Shares Outstanding

Annual figures by period end, from SEC filings.

51.94M
As of 2025-12-31
+34.0%
3-year compound annual growth
2022-12-31: 21.59M2023-12-31: 27.28M2024-12-31: 35.64M2025-12-31: 51.94M51.94M
2022-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3151.94M+45.7%2026-03-13, Balance as of period end
2024-12-3135.64M+30.6%2026-03-13, Balance as of period end
2023-12-3127.28M+26.3%2025-03-20, Balance as of period end
2022-12-3121.59Mn/a2024-04-01, Balance as of period end